BackQuest Diagnostics Overview

Quest Diagnostics Other Liabilities

Quest Diagnostics's other liabilities is $80M.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$80.00M

Peer average

Loading

Quest Diagnostics Other Liabilities History

Loading

Quest Diagnostics vs. peers: Other Liabilities Comparison

Loading

Quest Diagnostics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Quest Diagnostics (DGX) FAQ

Quest Diagnostics (DGX) currently reports a other liabilities of $80M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Quest Diagnostics's other liabilities history and peer comparisons.

Quest Diagnostics's other liabilities changed from $0 to $80M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Quest Diagnostics reported $80M in other liabilities as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $80M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quest Diagnostics, and consider following DGX for alerts when major investors trade the stock.

Quest Diagnostics is classified in the Healthcare sector. On other liabilities, it currently shows $80M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DGX with unrelated industries.